VENTOLIN Syrup Ref.[28325] Active ingredients: Salbutamol

Source: Υπουργείο Υγείας (CY)  Revision Year: 2020  Publisher: GlaxoSmithKline (Ireland) Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

4.1. Therapeutic indications

Ventolin Syrup is indicated in adults, adolescents and children aged 2 to 12 years.

Salbutamol is a selective beta-2 adrenoceptor agonist providing short-acting (4-6 hour) bronchodilation in reversible airways obstruction. Ventolin syrup can be used in the management of asthma, bronchospasm and/or reversible airways obstruction.
Relief of bronchospasm in bronchial asthma of all types.

Ventolin syrup is suitable oral therapy for children and adults who are unable to use an inhaler device.

4.2. Posology and method of administration

Route of administration: oral.

Adults

The minimum starting dose is 2 mg three times a day given as 5 ml syrup. The usual effective dose is 4 mg (10 ml syrup) three or four times a day, which may be increased to a maximum of 8 mg (20 ml syrup) three or four times a day if adequate bronchodilation is not obtained.

Elderly

In elderly patients or in those known to be unusually sensitive to beta-adrenergic stimulant drugs, it is advisable to initiate treatment with the minimum starting dose.

Paediatric Population

2-6 years: the minimum starting dose is 1 mg as 2.5 ml of syrup three times daily. This may be increased to 2 mg as 5 ml of syrup three or four times daily.

6-12 years: the minimum starting dose is 2 mg as 5 ml syrup three times daily. This may be increased to four times daily.

Over 12 years: the minimum starting dose is 2 mg three times daily given as 5 ml syrup. This may be increased to 4 mg as 10 ml syrup three or four times daily.

Ventolin is well tolerated by children so that, if necessary, these doses may be cautiously increased to the maximum dose.

For lower doses the syrup may be diluted with freshly prepared purified water BP.

4.9. Overdose

The most common signs and symptoms of overdose with salbutamol are transient beta agonist pharmacologically mediated events, including tachycardia, tremor, hyperactivity and metabolic effects including hypokalaemia (see sections 4.4 and 4.8).

Hypokalaemia may occur following overdose with salbutamol. Serum potassium levels should be monitored.

Lactic acidosis has been reported in association with high therapeutic doses as well as overdoses of short-acting beta-agonist therapy, therefore monitoring for elevated serum lactate and consequent metabolic acidosis (particularly if there is persistence or worsening of tachypnea despite resolution of other signs of bronchospasm such as wheezing) may be indicated in the setting of overdose.

Nausea, vomiting and hyperglycaemia have been reported, predominantly in children and when salbutamol overdose has been taken via the oral route.

Further management should be as clinically indicated or as recommended by the national poisons centre, where available.

6.3. Shelf life

36 months.

6.4. Special precautions for storage

Store at a temperature not exceeding 30°C.

Protect from light.

Ventolin syrup may be diluted with freshly Purified Water BP. The diluted mixture must be protected from light and stored below 25°C. Discard after 28 days.

6.5. Nature and contents of container

Type III amber glass bottle with plastic, child resistant, pilfer-proof caps with low density polyethylene polyvinylidene chloride low density polyethylene (LDPE-PVDC-LDPE) faced liners.

Pack size: 150 ml.

6.6. Special precautions for disposal and other handling

Ventolin syrup may be diluted with Purified Water BP (50% v/v). The resulting mixture should be protected from light and used within 28 days.

A 50% v/v dilution of Ventolin syrup has been shown to be adequately preserved against microbial contamination. However, to avoid the possibility of introducing excessive microbial contamination, the Purified Water used for dilution should be recently prepared or alternatively it should be boiled and cooled immediately before use.

Admixture of Ventolin syrup with other liquid preparation is not recommended.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.